Gemer 1 Tablet PR is a fixed-dose combination medication containing Glimepiride 1 mg and Metformin 500 mg, indicated for the management of type 2 diabetes mellitus. Glimepiride, a sulfonylurea class agent, stimulates pancreatic beta-cell insulin secretion, thereby reducing blood glucose levels. Metformin, a biguanide, primarily decreases hepatic glucose production and improves peripheral insulin sensitivity, enhancing glucose uptake by muscle tissues. The combination of these agents provides complementary mechanisms of action, facilitating improved glycemic control in patients inadequately managed by diet and exercise alone. Gemer 1 Tablet PR is typically prescribed when monotherapy with either agent is insufficient to achieve target glycemic levels. It is essential to administer this medication with meals to minimize gastrointestinal side effects commonly associated with Metformin, such as nausea and diarrhea. Patients should be monitored regularly for blood glucose levels, renal function, and potential adverse effects, including hypoglycemia, lactic acidosis, and vitamin B12 deficiency. Contraindications include severe renal impairment, metabolic acidosis, and hypersensitivity to any component. Dose adjustments may be necessary based on therapeutic response and tolerability. Gemer 1 Tablet PR should be used as part of a comprehensive diabetes management plan, including lifestyle modifications such as diet and exercise.

Dosage & How to Use